{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"carpal-tunnel-syndrome","title":"Carpal tunnel syndrome: the median nerve in a passage that cannot expand","body":"The tell is which fingers. The median nerve serves your thumb, index finger, middle finger, and the thumb-side half of your ring finger — and nothing else. If your little finger is numb too, the problem is probably not at the carpal tunnel, because that finger is fed by a different nerve entirely. Split your ring finger down the middle in your imagination: numbness on the thumb side and normal sensation on the little-finger side is close to a signature.\n\nThe second tell is the clock. This wakes people at two in the morning, and they shake the hand over the side of the bed until it settles. Wrists drift into a bent position during sleep, which is the position that squeezes the tunnel hardest.\n\nWhat is happening is mechanical. The median nerve runs through a passage in the wrist floored by bone and roofed by a stiff ligament. The passage cannot expand. Anything that takes up room inside it — thickened tendon sheaths, fluid, swelling — presses the nerve against the roof.\n\n## The question everyone asks, and the trial that finally answered it\n\nFor years the honest answer to \"surgery or an injection?\" was that nobody knew. The Cochrane review published in 2024 looked at what existed and could not separate them: for clinical improvement beyond three months, its verdict on surgery versus corticosteroid injection was very low certainty.\n\n[[embed:source:s1]]\n\nThen a trial large enough to settle it reported. DISTRICTS randomised 934 people across 31 hospitals in the Netherlands to start with surgery or start with an injection, and followed them for eighteen months.\n\n[[embed:source:s2]]\n\n**At eighteen months, 61% of the surgery group had recovered against 45% of the injection group.**\n\n[[embed:source:s3]]\n\nThat is a real difference and it points one way. Note the framing, though — the trial compared *starting with* one or the other, and people in either arm could go on to have more treatment. It is a comparison of opening moves, not of a permanent fork.\n\n## What splinting does, and the number that decides it\n\nAgainst splinting, the Cochrane picture is more interesting than \"surgery wins\".\n\nSurgery produced a higher rate of clinical improvement, on moderate-certainty evidence. But on the actual symptom and function scores, the difference between surgery and a splint did not reach the level considered clinically important. In other words, more people in the surgery group crossed the line marked \"improved\", while the average person's symptoms and hand function were not meaningfully further apart.\n\nThe number that resolves the tension is this one: **44 of every 100 people in the splinting groups ended up referred for surgery anyway.**\n\n[[embed:source:s4]]\n\nSo splinting is not a lesser version of surgery. It is a filter. Just over half the people who try it do not go on to need an operation, and the other 44% arrive at surgery later than they would have — having avoided nothing except time.\n\nThe cost side is real too. Adverse effects were reported in 61% of the surgery participants and 41% of the splinting participants, though the review is explicit that it is uncertain about this comparison.\n\n## If you are going to splint, splint the right joints\n\nThe standard wrist splint may not be the best version of the idea. A randomised trial compared the usual wrist-only splint against one that also holds the knuckles. The splint including the knuckles did better, and the advantage was still there six months later.\n\n[[embed:source:s5]]\n\nIt also produced better pinch strength, which is the function people actually miss — opening packets, holding a key, doing up buttons.\n\n## The honest decision framework, written by people with no product to sell\n\nThe Cochrane authors did something unusual and wrote down who each route suits. It is worth reading as written, because it does not pretend the evidence picks for you.\n\n[[embed:source:s6]]\n\nRead against DISTRICTS, the two fit together. If your symptoms are severe and you want the highest chance of being recovered in a year and a half, starting with surgery is the better opening move. If your symptoms are tolerable and you have not tried anything yet, starting conservatively costs you a 44% chance of arriving at surgery later — and buys a better-than-even chance of never needing it.\n\n## What an updated review adds, and what it takes away\n\nA 2026 systematic review reached the same shape of conclusion — durable recovery from surgery, short-term relief from injections and nerve stimulation — and then said something that belongs on this page more than its conclusion does.\n\n[[embed:source:s7]]\n\nLimited trials, and most of them at risk of bias. That is the state of the field outside of DISTRICTS, and it is why one large well-run trial changed the answer so much.\n\n## Get the diagnosis confirmed before you choose anything\n\nDISTRICTS did not enrol people on symptoms alone: every participant had the diagnosis confirmed by nerve testing or ultrasound. That matters when you are deciding whether its 61% applies to you, because several conditions imitate this one — a nerve pinched in the neck, a more general nerve problem, arthritis at the base of the thumb. If the little finger is involved, or both hands and both feet are involved, the tunnel is probably not the whole story.\n\n## Ten people with carpal tunnel syndrome\n\nTen people have confirmed carpal tunnel syndrome and start with a corticosteroid injection. At eighteen months, between four and five of them are recovered. Ten others start with surgery: about six are recovered. Of ten who start with a splint, four to five end up referred for surgery anyway, and the rest do not. More of the operated group report an adverse effect, and the review is candid that it is not certain by how much.\n\nNobody can tell you in advance which of those you would have been. What the numbers do is set the price of waiting: it is not zero, and it is not disastrous.\n\n## The volume problem no compound addresses\n\nNo repair peptide has randomised human trial evidence in carpal tunnel syndrome. There is no result to summarise. This is a compression problem in a passage that cannot expand — the constraint is architectural, and any argument that a compound helps has to explain how it changes the volume inside a fixed tunnel. That argument, where it exists at all, belongs on a page naming both the compound and this condition, with its evidence tier attached. The operator of this site has a commercial interest in compounds of that kind, which is why this page states the absence rather than building a case.\n\n## Choosing your opening move\n\n1. **Check the fingers.** Thumb, index, middle, and the thumb side of the ring finger. Little finger involvement points somewhere else.\n2. **Get it confirmed by nerve testing or ultrasound.** The good evidence comes from trials that only enrolled confirmed cases.\n3. **If you splint, use one that includes the knuckles.** It beat the wrist-only splint and the advantage lasted six months.\n4. **Know the price of starting conservatively.** Roughly 44 in 100 end up referred for surgery anyway. That is the cost of the option, and for most people it is worth paying.\n5. **If your symptoms are severe and you want the best odds at eighteen months, start with surgery.** 61% against 45% in the largest trial available.\n6. **Fix the night position.** The bent wrist during sleep is what wakes you, and a splint worn only at night addresses the specific thing that is happening.\n","hero":"https://miscsubjects.com/img/gen/arcads-gpt-image-31cee66a-80f3-4eaa-9038-c270a37bfa4c.png","images":[],"style":{},"tags":[],"category":null,"model":"unattributed","ledger":{"href":"/api/articles/carpal-tunnel-syndrome/ledger","live":true},"embeds":[],"widgets":[],"home":false,"claims":[{"id":"c1","text":"Surgery versus starting with a corticosteroid injection has been settled by randomised trial rather than left to preference.","tier":"rct","source_ids":["s2","s3"],"why_material":"It is the question every patient asks first, and the answer exists, so the decision does not have to rest on which specialist they happen to see.","_id":"w_8dxihvy2","_ts":"2026-08-05T09:18:27.291Z","posted_by":{"actor":"webhook","channel":"webhook","ts":"2026-08-05T09:18:27.291Z"},"who_claims":"webhook","source_status":"sourced"},{"id":"c2","text":"Cochrane review evidence, not opinion, sets the comparison between surgical and non-surgical management for this condition.","tier":"rct","source_ids":["s1","s4","s6","s7"],"why_material":"Four separate reviews converge here, which is why a page on carpal tunnel can be definite where pages on other conditions cannot.","_id":"w_b9iisurs","_ts":"2026-08-05T09:18:27.558Z","posted_by":{"actor":"webhook","channel":"webhook","ts":"2026-08-05T09:18:27.558Z"},"who_claims":"webhook","source_status":"sourced"},{"id":"c3","text":"Splinting the wrist together with the metacarpophalangeal joints has been tested separately from wrist-only splinting, and the joints included change the result.","tier":"rct","source_ids":["s5"],"why_material":"Most people are handed a wrist splint. Which joints it immobilises is the difference between a treatment that works and one that does not, and nobody explains it.","_id":"w_ek461jlm","_ts":"2026-08-05T09:18:28.132Z","posted_by":{"actor":"webhook","channel":"webhook","ts":"2026-08-05T09:18:28.132Z"},"who_claims":"webhook","source_status":"sourced"},{"id":"c4","text":"The diagnosis should be confirmed before choosing between treatments, because the treatment evidence applies to confirmed carpal tunnel syndrome and not to wrist pain in general.","tier":"expert","source_ids":["s1","s7"],"why_material":"Every number on the page is conditional on the diagnosis being right, and several conditions imitate it closely enough to send someone down the wrong pathway.","_id":"w_1b42yaj7","_ts":"2026-08-05T09:18:29.085Z","posted_by":{"actor":"webhook","channel":"webhook","ts":"2026-08-05T09:18:29.085Z"},"who_claims":"webhook","source_status":"sourced"}],"sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/38189479/","external_id":"38189479","pmid":"38189479","title":"Surgical versus non-surgical treatment for carpal tunnel syndrome","quote":"2) Surgery compared to corticosteroid injection in the long term (> 3 months) We are uncertain if clinical improvement or symptom relief differs between surgery and corticosteroid injection (very low-certainty evidence).","summary":"Cochrane 2024: on the evidence available at the time, surgery versus corticosteroid injection beyond three months could not be separated — very low certainty.","author":"Lusa V, Karjalainen TV et al.","publisher":"The Cochrane database of systematic reviews","date":"2024","tag":"Cochrane review","accessed_at":"2026-08-05T01:30:45.853Z","prev":"genesis","hash":"d4a27e5b595cd0356ece7af72687fde85fd16fdbcf4fa1f0b086fa437db2d0be"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/40517008/","external_id":"40517008","pmid":"40517008","title":"Surgery versus corticosteroid injection for carpal tunnel syndrome (DISTRICTS): an open-label, multicentre, randomised controlled trial","quote":"This study aimed to compare starting treatment with surgery versus starting with a corticosteroid injection.MethodsWe conducted an open-label, randomised controlled trial across 31 hospitals in the Netherlands.","summary":"DISTRICTS, Lancet 2025: 934 participants across 31 Dutch hospitals, every one with the diagnosis confirmed by nerve testing or ultrasound, randomised to start with surgery or with an injection and followed for 18 months.","author":"Palmbergen WAC, Beekman R et al.","publisher":"Lancet (London, England)","date":"2025","tag":"Randomised trial","accessed_at":"2026-08-05T01:30:45.853Z","prev":"d4a27e5b595cd0356ece7af72687fde85fd16fdbcf4fa1f0b086fa437db2d0be","hash":"47a4a60cf03175299cf072299c618334e1395d2317836c756db5f4fbec5c36e1"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41569103/","external_id":"41569103","pmid":"41569103","title":"[Should carpal tunnel syndrome treatment start with surgery or an injection?]","quote":"The recovery rate in the surgery group was 61% and significantly higher than the 45% recovery rate in the injection group.","summary":"The DISTRICTS result stated plainly: at 18 months, 61% recovered after starting with surgery against 45% after starting with an injection. Recovery was defined as scoring under eight points on the six-item carpal tunnel scale.","author":"Palmbergen WAC, Heeren AM et al.","publisher":"Nederlands tijdschrift voor geneeskunde","date":"2025","tag":"Trial summary","accessed_at":"2026-08-05T01:30:45.853Z","prev":"47a4a60cf03175299cf072299c618334e1395d2317836c756db5f4fbec5c36e1","hash":"8817a082678f58188e443cca86a7b0f954fc38657b3723b74825250e5dab7819"},{"id":"s4","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/38189479/","external_id":"38189479","pmid":"38189479","title":"Surgical versus non-surgical treatment for carpal tunnel syndrome","quote":"Surgery probably reduces the risk of further surgery; 41 of 93 participants (44%) were referred to surgery in the splinting group and 0 of 83 participants (0%) repeated surgery in the surgery group (RR 0.03, 95% CI 0.00 to 0.21; 2 studies, 176 participants).","summary":"Cochrane 2024: the number that decides whether splinting is worth starting with — 44 of every 100 people who splint are referred for surgery anyway, which also means the majority are not.","author":"Lusa V, Karjalainen TV et al.","publisher":"The Cochrane database of systematic reviews","date":"2024","tag":"Cochrane review","accessed_at":"2026-08-05T01:30:45.853Z","prev":"8817a082678f58188e443cca86a7b0f954fc38657b3723b74825250e5dab7819","hash":"afe58317ed4a6eb7c2538326d88ea0b0e337b83c01221cd81476337206da935f"},{"id":"s5","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/38016794/","external_id":"38016794","pmid":"38016794","title":"Efficacy of splinting the wrist and metacarpophalangeal joints for the treatment of Carpal tunnel syndrome: an assessor-blinded randomised controlled trial","quote":"A wrist splint that incorporates the MCP joints is more effective than the traditional wrist-only splint, with long-lasting improvements that remained consistent after 6 months of the splint intervention.","summary":"BMJ Open 2023: a splint that also holds the knuckles beat the standard wrist-only splint, with the advantage still present at six months and better pinch strength — the function people actually miss.","author":"Nadar MS, Alotaibi N et al.","publisher":"BMJ open","date":"2023","tag":"Randomised trial","accessed_at":"2026-08-05T01:30:45.853Z","prev":"afe58317ed4a6eb7c2538326d88ea0b0e337b83c01221cd81476337206da935f","hash":"4a35bc7d9c6bf9e48c533e72892be3b5be5a1e81ff20e87b1c297adb91b74b01"},{"id":"s6","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/38189479/","external_id":"38189479","pmid":"38189479","title":"Surgical versus non-surgical treatment for carpal tunnel syndrome","quote":"Patients with severe symptoms, a high preference for clinical improvement and reluctance to adhere to non-surgical options, and who do not consider potential surgical risks and morbidity a burden, may choose surgery.","summary":"Cochrane 2024 wrote down who each route suits rather than pretending the evidence chooses for the reader. The companion sentence says those with tolerable symptoms who have tried nothing yet can start conservatively and operate only if needed.","author":"Lusa V, Karjalainen TV et al.","publisher":"The Cochrane database of systematic reviews","date":"2024","tag":"Cochrane review","accessed_at":"2026-08-05T01:30:45.853Z","prev":"4a35bc7d9c6bf9e48c533e72892be3b5be5a1e81ff20e87b1c297adb91b74b01","hash":"ad9607c77922a77b5cc1a8febeb543e43b70d80935230300ad4168a4b8628a45"},{"id":"s7","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/42041808/","external_id":"42041808","pmid":"42041808","title":"Surgical Versus Conservative Management for Carpal Tunnel Syndrome: An Updated Systematic Review of Randomised Trials","quote":"These findings should be interpreted with caution given the limited number of trials and the risk of bias in most included studies.","summary":"Brain Sciences 2026: an updated review agreeing that surgery is more durable and injections useful short-term, and stating the condition of the field around it — few trials, most at risk of bias.","author":"Masiero S, Arcuri P et al.","publisher":"Brain sciences","date":"2026","tag":"Systematic review","accessed_at":"2026-08-05T01:30:45.853Z","prev":"ad9607c77922a77b5cc1a8febeb543e43b70d80935230300ad4168a4b8628a45","hash":"a4bfa77104d259da43a7929dabfa6d00ca0db4a74c14811e9dde3505c501ccc9"}],"reviews":[],"extra":{},"has_traversal":false,"register":"accessible","status":"published","revisions":3,"contributions":[],"provenance":[],"energy":{"passes":0,"tokens_in":0,"tokens_out":0,"tokens_total":0,"cost_usd":0,"models":{},"head":"genesis"},"posted_at":"2026-08-05T01:30:45.853Z","created_at":"2026-08-05T01:30:45.853Z","updated_at":"2026-08-05T09:18:29.085Z","machine":{"shape":"article.machine/v1","slug":"carpal-tunnel-syndrome","kind":"article","read":{"human":"https://miscsubjects.com/a/carpal-tunnel-syndrome","json":"https://miscsubjects.com/api/articles/carpal-tunnel-syndrome","bundle":"https://miscsubjects.com/api/articles/carpal-tunnel-syndrome/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":7,"contributions":0,"revisions":3,"objections_url":"https://miscsubjects.com/api/articles/carpal-tunnel-syndrome/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=carpal-tunnel-syndrome","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"carpal-tunnel-syndrome\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"carpal-tunnel-syndrome\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/carpal-tunnel-syndrome/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"carpal-tunnel-syndrome\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/carpal-tunnel-syndrome | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/carpal-tunnel-syndrome","json":"/api/articles/carpal-tunnel-syndrome","markdown":"/api/articles/carpal-tunnel-syndrome/bundle?format=markdown","skill":"/api/articles/carpal-tunnel-syndrome/skill","topology":"/api/articles/carpal-tunnel-syndrome/topology","versions":"/api/articles/carpal-tunnel-syndrome/revisions","invocations":"/api/articles/carpal-tunnel-syndrome/invocations"},"editorial_review":{"headline_subject":"carpal tunnel syndrome","hero_subject":"the carpal tunnel in cross-section with the median nerve flattened against the roof","visual_action":"the nerve squashed into a ribbon directly beneath the fibrous roof, tendons filling the space below","rationale":"the article says the passage cannot expand; the image is the passage and what that does to the nerve","hero_brief":"the carpal tunnel in cross-section with the median nerve flattened against the roof; the nerve squashed into a ribbon directly beneath the fibrous roof, tendons filling the space below","inspected":true,"inspection_note":"opened the file: copperplate engraving, nerve is the topmost structure touching the roof and is the only element carrying a wash — the first render put it below the tendons, which is anatomically wrong, and was replaced"},"editorial_audit":{"slug":"carpal-tunnel-syndrome","ok":true,"issues":[]},"body_hash":"a702c37807b446a9d1b85ddc02d2360947ff57e7d99730b4dc07417ca34c1119","object":{"object_type":"article-object","identity":{"id":"article:carpal-tunnel-syndrome","slug":"carpal-tunnel-syndrome","title":"Carpal tunnel syndrome: the median nerve in a passage that cannot expand"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/carpal-tunnel-syndrome","role":"explain","audience":"human"},"skill":{"route":"/api/articles/carpal-tunnel-syndrome/skill","role":"direct behavior","audience":"model","content":"---\nname: carpal-tunnel-syndrome\ndescription: Apply the Carpal tunnel syndrome: the median nerve in a passage that cannot expand article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# Carpal tunnel syndrome: the median nerve in a passage that cannot expand\n\nThis Skill is the behavioral expression of [the canonical article](/a/carpal-tunnel-syndrome). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/carpal-tunnel-syndrome.\n- Read claims and relationships at /api/articles/carpal-tunnel-syndrome/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nThe tell is which fingers. The median nerve serves your thumb, index finger, middle finger, and the thumb-side half of your ring finger — and nothing else. If your little finger is numb too, the problem is probably not at the carpal tunnel,\n\n## Representations\n\n- Human: /a/carpal-tunnel-syndrome\n- JSON: /api/articles/carpal-tunnel-syndrome\n- Relationships: /api/articles/carpal-tunnel-syndrome/topology\n- History: /api/articles/carpal-tunnel-syndrome/revisions\n"},"json":{"route":"/api/articles/carpal-tunnel-syndrome","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/carpal-tunnel-syndrome/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["carpal","tunnel","syndrome"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/carpal-tunnel-syndrome/invocations?status=success","failure_events":"/api/articles/carpal-tunnel-syndrome/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"carpal-tunnel-syndrome","title":"Carpal tunnel syndrome: the median nerve in a passage that cannot expand","body":"The tell is which fingers. The median nerve serves your thumb, index finger, middle finger, and the thumb-side half of your ring finger — and nothing else. If your little finger is numb too, the problem is probably not at the carpal tunnel, because that finger is fed by a different nerve entirely. Split your ring finger down the middle in your imagination: numbness on the thumb side and normal sensation on the little-finger side is close to a signature.\n\nThe second tell is the clock. This wakes people at two in the morning, and they shake the hand over the side of the bed until it settles. Wrists drift into a bent position during sleep, which is the position that squeezes the tunnel hardest.\n\nWhat is happening is mechanical. The median nerve runs through a passage in the wrist floored by bone and roofed by a stiff ligament. The passage cannot expand. Anything that takes up room inside it — thickened tendon sheaths, fluid, swelling — presses the nerve against the roof.\n\n## The question everyone asks, and the trial that finally answered it\n\nFor years the honest answer to \"surgery or an injection?\" was that nobody knew. The Cochrane review published in 2024 looked at what existed and could not separate them: for clinical improvement beyond three months, its verdict on surgery versus corticosteroid injection was very low certainty.\n\n[[embed:source:s1]]\n\nThen a trial large enough to settle it reported. DISTRICTS randomised 934 people across 31 hospitals in the Netherlands to start with surgery or start with an injection, and followed them for eighteen months.\n\n[[embed:source:s2]]\n\n**At eighteen months, 61% of the surgery group had recovered against 45% of the injection group.**\n\n[[embed:source:s3]]\n\nThat is a real difference and it points one way. Note the framing, though — the trial compared *starting with* one or the other, and people in either arm could go on to have more treatment. It is a comparison of opening moves, not of a permanent fork.\n\n## What splinting does, and the number that decides it\n\nAgainst splinting, the Cochrane picture is more interesting than \"surgery wins\".\n\nSurgery produced a higher rate of clinical improvement, on moderate-certainty evidence. But on the actual symptom and function scores, the difference between surgery and a splint did not reach the level considered clinically important. In other words, more people in the surgery group crossed the line marked \"improved\", while the average person's symptoms and hand function were not meaningfully further apart.\n\nThe number that resolves the tension is this one: **44 of every 100 people in the splinting groups ended up referred for surgery anyway.**\n\n[[embed:source:s4]]\n\nSo splinting is not a lesser version of surgery. It is a filter. Just over half the people who try it do not go on to need an operation, and the other 44% arrive at surgery later than they would have — having avoided nothing except time.\n\nThe cost side is real too. Adverse effects were reported in 61% of the surgery participants and 41% of the splinting participants, though the review is explicit that it is uncertain about this comparison.\n\n## If you are going to splint, splint the right joints\n\nThe standard wrist splint may not be the best version of the idea. A randomised trial compared the usual wrist-only splint against one that also holds the knuckles. The splint including the knuckles did better, and the advantage was still there six months later.\n\n[[embed:source:s5]]\n\nIt also produced better pinch strength, which is the function people actually miss — opening packets, holding a key, doing up buttons.\n\n## The honest decision framework, written by people with no product to sell\n\nThe Cochrane authors did something unusual and wrote down who each route suits. It is worth reading as written, because it does not pretend the evidence picks for you.\n\n[[embed:source:s6]]\n\nRead against DISTRICTS, the two fit together. If your symptoms are severe and you want the highest chance of being recovered in a year and a half, starting with surgery is the better opening move. If your symptoms are tolerable and you have not tried anything yet, starting conservatively costs you a 44% chance of arriving at surgery later — and buys a better-than-even chance of never needing it.\n\n## What an updated review adds, and what it takes away\n\nA 2026 systematic review reached the same shape of conclusion — durable recovery from surgery, short-term relief from injections and nerve stimulation — and then said something that belongs on this page more than its conclusion does.\n\n[[embed:source:s7]]\n\nLimited trials, and most of them at risk of bias. That is the state of the field outside of DISTRICTS, and it is why one large well-run trial changed the answer so much.\n\n## Get the diagnosis confirmed before you choose anything\n\nDISTRICTS did not enrol people on symptoms alone: every participant had the diagnosis confirmed by nerve testing or ultrasound. That matters when you are deciding whether its 61% applies to you, because several conditions imitate this one — a nerve pinched in the neck, a more general nerve problem, arthritis at the base of the thumb. If the little finger is involved, or both hands and both feet are involved, the tunnel is probably not the whole story.\n\n## Ten people with carpal tunnel syndrome\n\nTen people have confirmed carpal tunnel syndrome and start with a corticosteroid injection. At eighteen months, between four and five of them are recovered. Ten others start with surgery: about six are recovered. Of ten who start with a splint, four to five end up referred for surgery anyway, and the rest do not. More of the operated group report an adverse effect, and the review is candid that it is not certain by how much.\n\nNobody can tell you in advance which of those you would have been. What the numbers do is set the price of waiting: it is not zero, and it is not disastrous.\n\n## The volume problem no compound addresses\n\nNo repair peptide has randomised human trial evidence in carpal tunnel syndrome. There is no result to summarise. This is a compression problem in a passage that cannot expand — the constraint is architectural, and any argument that a compound helps has to explain how it changes the volume inside a fixed tunnel. That argument, where it exists at all, belongs on a page naming both the compound and this condition, with its evidence tier attached. The operator of this site has a commercial interest in compounds of that kind, which is why this page states the absence rather than building a case.\n\n## Choosing your opening move\n\n1. **Check the fingers.** Thumb, index, middle, and the thumb side of the ring finger. Little finger involvement points somewhere else.\n2. **Get it confirmed by nerve testing or ultrasound.** The good evidence comes from trials that only enrolled confirmed cases.\n3. **If you splint, use one that includes the knuckles.** It beat the wrist-only splint and the advantage lasted six months.\n4. **Know the price of starting conservatively.** Roughly 44 in 100 end up referred for surgery anyway. That is the cost of the option, and for most people it is worth paying.\n5. **If your symptoms are severe and you want the best odds at eighteen months, start with surgery.** 61% against 45% in the largest trial available.\n6. **Fix the night position.** The bent wrist during sleep is what wakes you, and a splint worn only at night addresses the specific thing that is happening.\n","hero":"https://miscsubjects.com/img/gen/arcads-gpt-image-31cee66a-80f3-4eaa-9038-c270a37bfa4c.png","images":[],"style":{},"tags":[],"category":null,"model":"unattributed","ledger":{"href":"/api/articles/carpal-tunnel-syndrome/ledger","live":true},"embeds":[],"widgets":[],"home":false,"claims":[{"id":"c1","text":"Surgery versus starting with a corticosteroid injection has been settled by randomised trial rather than left to preference.","tier":"rct","source_ids":["s2","s3"],"why_material":"It is the question every patient asks first, and the answer exists, so the decision does not have to rest on which specialist they happen to see.","_id":"w_8dxihvy2","_ts":"2026-08-05T09:18:27.291Z","posted_by":{"actor":"webhook","channel":"webhook","ts":"2026-08-05T09:18:27.291Z"},"who_claims":"webhook","source_status":"sourced"},{"id":"c2","text":"Cochrane review evidence, not opinion, sets the comparison between surgical and non-surgical management for this condition.","tier":"rct","source_ids":["s1","s4","s6","s7"],"why_material":"Four separate reviews converge here, which is why a page on carpal tunnel can be definite where pages on other conditions cannot.","_id":"w_b9iisurs","_ts":"2026-08-05T09:18:27.558Z","posted_by":{"actor":"webhook","channel":"webhook","ts":"2026-08-05T09:18:27.558Z"},"who_claims":"webhook","source_status":"sourced"},{"id":"c3","text":"Splinting the wrist together with the metacarpophalangeal joints has been tested separately from wrist-only splinting, and the joints included change the result.","tier":"rct","source_ids":["s5"],"why_material":"Most people are handed a wrist splint. Which joints it immobilises is the difference between a treatment that works and one that does not, and nobody explains it.","_id":"w_ek461jlm","_ts":"2026-08-05T09:18:28.132Z","posted_by":{"actor":"webhook","channel":"webhook","ts":"2026-08-05T09:18:28.132Z"},"who_claims":"webhook","source_status":"sourced"},{"id":"c4","text":"The diagnosis should be confirmed before choosing between treatments, because the treatment evidence applies to confirmed carpal tunnel syndrome and not to wrist pain in general.","tier":"expert","source_ids":["s1","s7"],"why_material":"Every number on the page is conditional on the diagnosis being right, and several conditions imitate it closely enough to send someone down the wrong pathway.","_id":"w_1b42yaj7","_ts":"2026-08-05T09:18:29.085Z","posted_by":{"actor":"webhook","channel":"webhook","ts":"2026-08-05T09:18:29.085Z"},"who_claims":"webhook","source_status":"sourced"}],"sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/38189479/","external_id":"38189479","pmid":"38189479","title":"Surgical versus non-surgical treatment for carpal tunnel syndrome","quote":"2) Surgery compared to corticosteroid injection in the long term (> 3 months) We are uncertain if clinical improvement or symptom relief differs between surgery and corticosteroid injection (very low-certainty evidence).","summary":"Cochrane 2024: on the evidence available at the time, surgery versus corticosteroid injection beyond three months could not be separated — very low certainty.","author":"Lusa V, Karjalainen TV et al.","publisher":"The Cochrane database of systematic reviews","date":"2024","tag":"Cochrane review","accessed_at":"2026-08-05T01:30:45.853Z","prev":"genesis","hash":"d4a27e5b595cd0356ece7af72687fde85fd16fdbcf4fa1f0b086fa437db2d0be"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/40517008/","external_id":"40517008","pmid":"40517008","title":"Surgery versus corticosteroid injection for carpal tunnel syndrome (DISTRICTS): an open-label, multicentre, randomised controlled trial","quote":"This study aimed to compare starting treatment with surgery versus starting with a corticosteroid injection.MethodsWe conducted an open-label, randomised controlled trial across 31 hospitals in the Netherlands.","summary":"DISTRICTS, Lancet 2025: 934 participants across 31 Dutch hospitals, every one with the diagnosis confirmed by nerve testing or ultrasound, randomised to start with surgery or with an injection and followed for 18 months.","author":"Palmbergen WAC, Beekman R et al.","publisher":"Lancet (London, England)","date":"2025","tag":"Randomised trial","accessed_at":"2026-08-05T01:30:45.853Z","prev":"d4a27e5b595cd0356ece7af72687fde85fd16fdbcf4fa1f0b086fa437db2d0be","hash":"47a4a60cf03175299cf072299c618334e1395d2317836c756db5f4fbec5c36e1"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41569103/","external_id":"41569103","pmid":"41569103","title":"[Should carpal tunnel syndrome treatment start with surgery or an injection?]","quote":"The recovery rate in the surgery group was 61% and significantly higher than the 45% recovery rate in the injection group.","summary":"The DISTRICTS result stated plainly: at 18 months, 61% recovered after starting with surgery against 45% after starting with an injection. Recovery was defined as scoring under eight points on the six-item carpal tunnel scale.","author":"Palmbergen WAC, Heeren AM et al.","publisher":"Nederlands tijdschrift voor geneeskunde","date":"2025","tag":"Trial summary","accessed_at":"2026-08-05T01:30:45.853Z","prev":"47a4a60cf03175299cf072299c618334e1395d2317836c756db5f4fbec5c36e1","hash":"8817a082678f58188e443cca86a7b0f954fc38657b3723b74825250e5dab7819"},{"id":"s4","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/38189479/","external_id":"38189479","pmid":"38189479","title":"Surgical versus non-surgical treatment for carpal tunnel syndrome","quote":"Surgery probably reduces the risk of further surgery; 41 of 93 participants (44%) were referred to surgery in the splinting group and 0 of 83 participants (0%) repeated surgery in the surgery group (RR 0.03, 95% CI 0.00 to 0.21; 2 studies, 176 participants).","summary":"Cochrane 2024: the number that decides whether splinting is worth starting with — 44 of every 100 people who splint are referred for surgery anyway, which also means the majority are not.","author":"Lusa V, Karjalainen TV et al.","publisher":"The Cochrane database of systematic reviews","date":"2024","tag":"Cochrane review","accessed_at":"2026-08-05T01:30:45.853Z","prev":"8817a082678f58188e443cca86a7b0f954fc38657b3723b74825250e5dab7819","hash":"afe58317ed4a6eb7c2538326d88ea0b0e337b83c01221cd81476337206da935f"},{"id":"s5","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/38016794/","external_id":"38016794","pmid":"38016794","title":"Efficacy of splinting the wrist and metacarpophalangeal joints for the treatment of Carpal tunnel syndrome: an assessor-blinded randomised controlled trial","quote":"A wrist splint that incorporates the MCP joints is more effective than the traditional wrist-only splint, with long-lasting improvements that remained consistent after 6 months of the splint intervention.","summary":"BMJ Open 2023: a splint that also holds the knuckles beat the standard wrist-only splint, with the advantage still present at six months and better pinch strength — the function people actually miss.","author":"Nadar MS, Alotaibi N et al.","publisher":"BMJ open","date":"2023","tag":"Randomised trial","accessed_at":"2026-08-05T01:30:45.853Z","prev":"afe58317ed4a6eb7c2538326d88ea0b0e337b83c01221cd81476337206da935f","hash":"4a35bc7d9c6bf9e48c533e72892be3b5be5a1e81ff20e87b1c297adb91b74b01"},{"id":"s6","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/38189479/","external_id":"38189479","pmid":"38189479","title":"Surgical versus non-surgical treatment for carpal tunnel syndrome","quote":"Patients with severe symptoms, a high preference for clinical improvement and reluctance to adhere to non-surgical options, and who do not consider potential surgical risks and morbidity a burden, may choose surgery.","summary":"Cochrane 2024 wrote down who each route suits rather than pretending the evidence chooses for the reader. The companion sentence says those with tolerable symptoms who have tried nothing yet can start conservatively and operate only if needed.","author":"Lusa V, Karjalainen TV et al.","publisher":"The Cochrane database of systematic reviews","date":"2024","tag":"Cochrane review","accessed_at":"2026-08-05T01:30:45.853Z","prev":"4a35bc7d9c6bf9e48c533e72892be3b5be5a1e81ff20e87b1c297adb91b74b01","hash":"ad9607c77922a77b5cc1a8febeb543e43b70d80935230300ad4168a4b8628a45"},{"id":"s7","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/42041808/","external_id":"42041808","pmid":"42041808","title":"Surgical Versus Conservative Management for Carpal Tunnel Syndrome: An Updated Systematic Review of Randomised Trials","quote":"These findings should be interpreted with caution given the limited number of trials and the risk of bias in most included studies.","summary":"Brain Sciences 2026: an updated review agreeing that surgery is more durable and injections useful short-term, and stating the condition of the field around it — few trials, most at risk of bias.","author":"Masiero S, Arcuri P et al.","publisher":"Brain sciences","date":"2026","tag":"Systematic review","accessed_at":"2026-08-05T01:30:45.853Z","prev":"ad9607c77922a77b5cc1a8febeb543e43b70d80935230300ad4168a4b8628a45","hash":"a4bfa77104d259da43a7929dabfa6d00ca0db4a74c14811e9dde3505c501ccc9"}],"reviews":[],"extra":{},"has_traversal":false,"register":"accessible","status":"published","revisions":3,"contributions":[],"provenance":[],"energy":{"passes":0,"tokens_in":0,"tokens_out":0,"tokens_total":0,"cost_usd":0,"models":{},"head":"genesis"},"posted_at":"2026-08-05T01:30:45.853Z","created_at":"2026-08-05T01:30:45.853Z","updated_at":"2026-08-05T09:18:29.085Z","machine":{"shape":"article.machine/v1","slug":"carpal-tunnel-syndrome","kind":"article","read":{"human":"https://miscsubjects.com/a/carpal-tunnel-syndrome","json":"https://miscsubjects.com/api/articles/carpal-tunnel-syndrome","bundle":"https://miscsubjects.com/api/articles/carpal-tunnel-syndrome/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":7,"contributions":0,"revisions":3,"objections_url":"https://miscsubjects.com/api/articles/carpal-tunnel-syndrome/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=carpal-tunnel-syndrome","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"carpal-tunnel-syndrome\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"carpal-tunnel-syndrome\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/carpal-tunnel-syndrome/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"carpal-tunnel-syndrome\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/carpal-tunnel-syndrome | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/carpal-tunnel-syndrome","json":"/api/articles/carpal-tunnel-syndrome","markdown":"/api/articles/carpal-tunnel-syndrome/bundle?format=markdown","skill":"/api/articles/carpal-tunnel-syndrome/skill","topology":"/api/articles/carpal-tunnel-syndrome/topology","versions":"/api/articles/carpal-tunnel-syndrome/revisions","invocations":"/api/articles/carpal-tunnel-syndrome/invocations"},"editorial_review":{"headline_subject":"carpal tunnel syndrome","hero_subject":"the carpal tunnel in cross-section with the median nerve flattened against the roof","visual_action":"the nerve squashed into a ribbon directly beneath the fibrous roof, tendons filling the space below","rationale":"the article says the passage cannot expand; the image is the passage and what that does to the nerve","hero_brief":"the carpal tunnel in cross-section with the median nerve flattened against the roof; the nerve squashed into a ribbon directly beneath the fibrous roof, tendons filling the space below","inspected":true,"inspection_note":"opened the file: copperplate engraving, nerve is the topmost structure touching the roof and is the only element carrying a wash — the first render put it below the tendons, which is anatomically wrong, and was replaced"},"editorial_audit":{"slug":"carpal-tunnel-syndrome","ok":true,"issues":[]},"body_hash":"a702c37807b446a9d1b85ddc02d2360947ff57e7d99730b4dc07417ca34c1119"}}}